Tumor growth curves and tumor weight analyses in these CD8-depleted groups demonstrated a reversal of tetrandrine’s inhibitory effects, further highlighting the critical role of CD8+ T cells in this process (Fig. 7g–j). The gene discussed is CD8A; the disease is neoplasm.